Last reviewed · How we verify
SSS17
At a glance
| Generic name | SSS17 |
|---|---|
| Sponsor | Shenyang Sunshine Pharmaceutical Co., LTD. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males (PHASE1)
- Phase II Dose-Finding of Oral SSS17 for Anemia in Non-Dialysis CKD (PHASE2)
- A Study Evaluating the Food Effect on the Pharmacokinetics of SSS17 Capsules in Chinese Healthy Subjects (PHASE1)
- Phase IIa Trial of Oral SSS17 for Post-Arthroplasty Anemia (PHASE2)
- A Phase 1 Study of SSS17 in Healthy Subjects. (PHASE1)
- A Study of SSS17 in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SSS17 CI brief — competitive landscape report
- SSS17 updates RSS · CI watch RSS
- Shenyang Sunshine Pharmaceutical Co., LTD. portfolio CI